Inmune Bio Inc. (INMB)
NASDAQ · Healthcare
Inmune Bio Inc. Revenue 2017–2025
Inmune Bio Inc. annual/quarterly revenue history and growth rate from 2017 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Inmune Bio Inc. revenue for the quarter ending March 31, 2025 was 50000, a 257.14% increase year-over-year.
- Inmune Bio Inc. revenue for the twelve months ending March 31, 2025 was 153000, a 51.43% decrease year-over-year.
- Inmune Bio Inc. annual revenue for 2025 was 50000, a 257.14% increase from 2024.
- Inmune Bio Inc. annual revenue for 2024 was 14000, a 90.97% decrease from 2023.
- Inmune Bio Inc. annual revenue for 2023 was 155000, a 58.56% decrease from 2022.
- Inmune Bio Inc. annual revenue for 2022 was 374000.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Inmune Bio Inc. Market Cap — FAQ
Inmune Bio Inc. (INMB) market cap over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INMB's market cap history?
The chart and table above show Inmune Bio Inc.'s market cap by year and by quarter, including the growth rate.